Utrecht-based Moveshelf wins Children's Hospital Los Angeles as a client and joins European home care project

Utrecht-based company Moveshelf has integrated its motion analysis platform into the Motion and Sports Analysis Lab at Children's Hospital Los Angeles (CHLA). The hospital is using the system to improve paediatric care through structured analysis of movement data. At the same time, Moveshelf has announced its participation in the RE:HOME project, a European initiative developing smart technologies for personalised home care for children with neurological conditions.

Moveshelf, founded in 2017 in Utrecht, offers a central platform that enables clinics to store, manage and analyse movement and gait data. The company raised a Series A round of €1.7 million in 2022 and focuses primarily on clinical and educational environments where movement research plays a role.

What Moveshelf does at Children's Hospital Los Angeles

The Motion and Sports Analysis Lab at CHLA uses Moveshelf's platform to capture and share movement data from young patients in a structured way. This is relevant in a clinical environment where multiple care providers, researchers and analysts need access to the same datasets, ideally without relying on fragmented local storage or proprietary formats.

Moveshelf positions its system as a platform-independent solution that works with data from various measurement setups and motion analysis equipment. It is applicable across a range of clinical contexts, from gait analysis to sports medicine. The collaboration with CHLA represents a concrete step towards the North American market, where paediatric rehabilitation and movement science have a substantial clinical infrastructure.

RE:HOME targets neurological care at home

Alongside the collaboration in Los Angeles, Moveshelf is participating in RE:HOME, a project developing technologies for personalised home care for children with neurological conditions. The project combines wearable sensors, data analysis and care protocols to translate treatments that normally take place exclusively in clinical settings, at least in part, to the home environment.

For Moveshelf, participation in RE:HOME fits within a broader strategy to make movement data useful beyond hospital walls. Home measurement increases the number of data points that clinicians can collect over longer periods, which is relevant in chronic neurological conditions where recovery or deterioration progresses slowly. Concrete project outcomes or an end date for RE:HOME are not known based on available source material.

Moveshelf's market position

Moveshelf operates in a niche market: the clinical management of movement data. Large hospitals collect large volumes of data through gait analysis, force platforms and optical systems, but the infrastructure to systematically store and access that data is often fragmented. Moveshelf addresses that bottleneck.

With a Series A of €1.7 million raised in early 2022, the company is modestly funded by Dutch standards. The collaboration with CHLA and participation in RE:HOME expand both the client base and the breadth of applications for the platform. Whether these steps have yet translated into significant revenue growth cannot be determined based on publicly available information.

For the Dutch and broader European healthtech scene, Moveshelf illustrates that a platform approach in a narrow medical niche can attract international clients, even with limited funding. That is a relevant data point for founders and investors looking at B2B software in healthcare, a sector where long sales cycles and stringent data requirements keep the barrier high, but where market position, once established, can be stable.